Shanghai Hile Bio-Technology (603718)

Shanghai Hile Bio-Technology (603718)

$ 10

Trading Risk Analysis

English Version

Date : 1 Feb 2021


SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. is principally engaged in the research & development, production and sales of veterinary biological products. The Company’s products mainly include escherichia coli (K88 and K99) gene modified vaccines for piglets, inactivated; porcine reproductive and respiratory syndrome vaccines, live and swine infectious atrophic rhinitis vaccines, inactivated; newcastle disease mild vaccines, living; newcastle disease, infectious bronchitis, egg drop syndrome’76 vaccines, inactivated and infectious bronchitis vaccines, living, among others. The Company distributes its products mainly in China.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner